Last November, VC firm Thoma Brava closed an investment in open source Java specialist Azul, becoming its leading backer. Shortly afterwards Azul announced its first ...

UiPath is at an inflection point, with stabilizing SaaS metrics, renewed growth, and a strong AI-driven product roadmap. PATH’s Maestro platform uniquely integrates deterministic RPA and probabilistic ...

Executing a new strategy nearly always involves acquiring new resources and capabilities. Since firms can’t possibly get everything they need through internal development, it seems reasonable in ...

Adoptive cell therapy (ACT) is a treatment that uses a cancer patient's own T lymphocytes with anti-tumour activity, expanded in vitro and reinfused into the patient with cancer. ACT using autologous ...